Balancing Treatment and Quality of Life: Adverse Events of First-Line Agents in NSCLC

EP: 1.Overcoming Challenges in NSCLC Management From a Pharmacist’s Perspective

EP: 2.First-Line Focus: Molecular Testing and Guideline-Directed Therapy in EGFR-Positive NSCLC

EP: 3.Recent Clinical Trial Highlights for NSCLC Treatment

EP: 4.Integrating Clinical Trial Findings Into Everyday Pharmacy Practice

EP: 5.Barriers to Bridging Clinical Trial Data to Routine Pharmacy Practice

EP: 6.Enhancing Patient Care Through Multidisciplinary Team Collaboration in Management of NSCLC

EP: 7.Breaking New Ground: Emerging Therapies for Treatment of EGFR-Positive NSCLC

Now Viewing

EP: 8.Balancing Treatment and Quality of Life: Adverse Events of First-Line Agents in NSCLC

EP: 9.Strategies to Minimize Toxicities, and the Pharmacist’s Role in Educating and Supporting Patients With NSCLC

Adverse Events of EGFR TKIs: Summary for Physicians

Based on the transcript, the most common adverse events associated with EGFR TKIs are:

Dermatologic Toxicities

• Acneiform rash: Typically affects face, upper chest, back, and shoulders
• More common in men than in women

• Can range from mild to severe with potential for superimposed infection

• Management varies by grade/body surface area affected

• Severe cases may require topical and oral antibiotics
• Dry skin: Requires regular moisturizing with creamy products
• Associated itching can disrupt sleep and impact quality of life
• Paronychia: Presentations include nail flaking, cracking, nail bed/cuticle inflammation
• Can progress to abscess formation and nail loss in severe cases

• Management options include vinegar soaks and dermatology referral
• Photosensitivity: Increased skin sensitivity to sunlight

Gastrointestinal Effects

• Diarrhea: Second most common adverse event
• Ranges from increased frequency with formed stool to loose/watery diarrhea

• Associated urgency significantly impacts quality of life

• Patients may limit activities due to unpredictability

Quality-of-Life Impact

• Dermatologic toxicities may cause embarrassment, leading to social isolation
• Diarrhea can restrict patients’ ability to leave home
• Both categories of adverse effects may necessitate dose adjustments

This summary highlights the importance of proactive symptom management to maintain treatment efficacy and patient quality of life.